Stock Analysts

ViaSat (VSAT) Posts Earnings in Q2, Revenues Top Estimates

After two consecutive quarters of a miss, ViaSat Inc. VSAT posted impressive results for second-quarter fiscal 2017, with adjusted earnings (including stock-based compensation adjustments) of 24 cents comparing favorably with the Zacks Consensus Estimate of a loss of 2 cents. Non-GAAP earnings came in at 40 cents, up 33.3% from 30 cents in the year-ago quarter. […]

Stock Analysts

Business Services Stocks’ Earnings on Nov 10: MMS & STN

We are nearing the end of Q3 earnings, with over 84% of the total S&P 500 index members having released their quarterly results through Nov 4. Results have improved considerably from the previous quarters and are expected to end up in the positive territory after five consecutive quarters of earnings decline for the S&P 500 index. Per our latest Earnings Preview report, combining the actual results from the 423 S&P 500 members with estimates from the soon-to-be-report 77 index members, overall Q3 earnings are expected to be up 3% on a 1.5% growth in revenues […]

Stock Analysts

Middleby (MIDD) Beats Q3 Earnings on Acquisition Benefits

Machinery behemoth, The Middleby Corporatio n MIDD , reported mixed third-quarter 2016 results. Though the company’s top line lagged the Zacks Consensus Estimate, the bottom line surpassed expectations. The company’s quarterly earnings of $1.33 cents per share surpassed the Zacks Consensus Estimate of $1.25. […]

Stock Analysts

Biotech Stock Roundup: Ionis Soars on Spinraza Data, Regeneron’s Q3 Results Mixed

With third quarter earnings season winding down, the only major biotech company to report results over the last five trading days was Regeneron REGN . While some small and mid-sized biotechs are yet to report results, focus is back on pipeline and regulatory updates. Recap of the Week’s Most Important Stories Ionis Jumps on Study Data: Ionis’ IONS shares soared on positive interim data from a late-stage study on Spinraza, an investigational treatment being evaluated in collaboration with Biogen for spinal muscular atrophy (SMA). […]

Momentum Stocks

Bear of the Day: Manitowoc (MTW)

The Manitowoc Company ( MTW ) is still stuck in the downward spiral of the mobile crane business. This Zacks Rank #5 (Strong Sell) does not see an end to the challenging market conditions yet. Manitowoc makes cranes and lift solutions in 20 countries. […]

Stock Analysts

Train Your Brain for Better Trading

When Denise Shull earned her Masters in Neuroscience from the University of Chicago in 1995, she didn’t imagine she would become a go-to consultant and coach for world-class traders ten years later, much less for Olympic athletes this year. But that’s what has transpired in her career as someone deeply interested in human emotion and decision-making. […]